Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-24-005018
Filing Date
2024-07-24
Accepted
2024-07-24 07:30:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA 14A sonoma_defa14a.htm DEFA14A 6642
2 GRAPHIC image_001.jpg GRAPHIC 3769
3 GRAPHIC image_002.jpg GRAPHIC 3378
  Complete submission text file 0001683168-24-005018.txt   17887
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-33216 | Film No.: 241136111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)